Showing results (51-60 of 478) with videos related to
Sort By:
Pageof 48
Biochemical Society Transactions|November 1, 2006
PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseasesR Bordet, T Ouk, O Petrault, et al.Biochemical and Biophysical Research Communications|February 12, 1998
Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbitsG Lebuffe, A Boullier, A Tailleux, et al.Expert Opinion on Pharmacotherapy|February 5, 2002
Current practice in the treatment of hyperlipidaemiasP DuriezJournal of Cardiovascular Pharmacology|October 22, 1998
A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cellsE Walters-Laporte, C Furman, S Fouquet, et al.Clinical Genetics|October 1, 1991
Apolipoprotein B polymorphism and altered apolipoprotein B concentrations in Congolese blacksH J Parra, F Martin, F Monard, et al.Journal of Lipid Research|February 1, 1989
Apolipoprotein B metabolism in homozygous familial hypercholesterolemiaR W James, B Martin, D Pometta, et al.Bulletin De L'Academie Nationale De Medecine|January 1, 1991
[From cholesterol to lipoprotein particle markers and/or risk factors]J C Fruchart, J CottetClinical Chemistry|June 1, 1992
Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significanceJ C Fruchart, G AilhaudBiotechnology Therapeutics|January 1, 1994
Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathwaysH Sqalli-Houssaini, C Pierlot, J P Kusnierz, et al.Journal of Immunological Methods|September 24, 1987
A monoclonal antibody (BIP 45) detects Ag(c,g) polymorphism of human apolipoprotein BP Duriez, R Butler, M J Tikkanen, et al.Pageof 48